• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿酸转运体ABCG2在慢性肾脏病5/6肾切除大鼠模型的肠道中表达增加。

Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

作者信息

Yano Hirofumi, Tamura Yoshifuru, Kobayashi Kana, Tanemoto Masayuki, Uchida Shunya

机构信息

Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, Japan.

出版信息

Clin Exp Nephrol. 2014 Feb;18(1):50-5. doi: 10.1007/s10157-013-0806-8. Epub 2013 Apr 13.

DOI:10.1007/s10157-013-0806-8
PMID:23584883
Abstract

BACKGROUND

Uric acid (UA) remains a risk factor of chronic kidney disease (CKD). Therefore, it is important to clarify the mechanism of UA excretion in CKD. The specific mechanisms of extrarenal excretion from the intestine are unknown. We evaluated the expression of the UA transporter in the intestinal tract--the ATP-binding cassette transporter G2 (ABCG2)--in a 5/6 nephrectomy rat model of CKD.

METHODS

Male Wistar rats (6 weeks old) were randomly assigned to the 5/6 nephrectomized (Nx) group or the sham-operated control group. Urine and blood samples were collected every 4 weeks. All the rats were killed at 8 weeks to obtain liver, duodenum, jejunum, ileum, and transverse colon tissues. Uricase activity was measured in the liver. Expression of ABCG2 in intestinal mucosa was measured with real time polymerase chain reaction (PCR).

RESULTS

The Nx group showed significantly decreased urine UA excretion/body weight and UA clearance compared to the control group at 4 and 8 weeks after nephrectomy. In contrast, serum UA and uricase activity were not significant. The expression of ABCG2 in the ileum of the Nx group showed significantly increased upregulation, while no changes were seen in the intestines of the control group.

CONCLUSIONS

The Nx rats exhibited lower excretion of urine UA and over-expression of ABCG2 in the ileum. The fact that serum UA did not increase despite the decrease in UA excretion suggests that an excretory pathway other than the kidney, probably the intestine, may operate in a complementary role that corroborates the increase in ABCG2 expression in the ileum.

摘要

背景

尿酸(UA)仍然是慢性肾脏病(CKD)的一个危险因素。因此,阐明CKD中UA排泄的机制很重要。肠道肾外排泄的具体机制尚不清楚。我们在CKD的5/6肾切除大鼠模型中评估了肠道中UA转运体——ATP结合盒转运体G2(ABCG2)的表达。

方法

将6周龄雄性Wistar大鼠随机分为5/6肾切除(Nx)组或假手术对照组。每4周采集尿液和血液样本。所有大鼠在8周时处死,获取肝脏、十二指肠、空肠、回肠和横结肠组织。测定肝脏中的尿酸酶活性。用实时聚合酶链反应(PCR)测量肠道黏膜中ABCG2的表达。

结果

与对照组相比,Nx组在肾切除后4周和8周时尿UA排泄/体重和UA清除率显著降低。相比之下,血清UA和尿酸酶活性无显著变化。Nx组回肠中ABCG2的表达显著上调,而对照组肠道中未见变化。

结论

Nx大鼠尿UA排泄降低,回肠中ABCG2过表达。尽管UA排泄减少,但血清UA并未升高,这一事实表明,除肾脏外的另一条排泄途径,可能是肠道,可能起到了补充作用,这与回肠中ABCG2表达增加相一致。

相似文献

1
Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.尿酸转运体ABCG2在慢性肾脏病5/6肾切除大鼠模型的肠道中表达增加。
Clin Exp Nephrol. 2014 Feb;18(1):50-5. doi: 10.1007/s10157-013-0806-8. Epub 2013 Apr 13.
2
Uric acid metabolism of kidney and intestine in a rat model of chronic kidney disease.慢性肾脏病大鼠模型中肾脏和肠道的尿酸代谢
Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):550-558. doi: 10.1080/15257770.2016.1163379.
3
Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.肠道腔尿酸排泄的电化学分析:血清尿酸降低药物和 5/6 肾切除对肠道尿酸水平的影响。
PLoS One. 2019 Dec 31;14(12):e0226918. doi: 10.1371/journal.pone.0226918. eCollection 2019.
4
Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2.胰岛素通过调节尿酸转运蛋白1和ATP结合盒亚家族G成员2来刺激尿酸重吸收。
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F826-F834. doi: 10.1152/ajprenal.00012.2017. Epub 2017 Jul 5.
5
Oral uricase eliminates blood uric acid in the hyperuricemic pig model.口服尿酸酶可降低高尿酸血症猪模型的血尿酸水平。
PLoS One. 2017 Jun 8;12(6):e0179195. doi: 10.1371/journal.pone.0179195. eCollection 2017.
6
ABCG2 expression and uric acid metabolism of the intestine in hyperuricemia model rat.高尿酸血症模型大鼠肠道ABCG2表达与尿酸代谢
Nucleosides Nucleotides Nucleic Acids. 2020;39(5):744-759. doi: 10.1080/15257770.2019.1694684. Epub 2020 Jan 25.
7
06CC2 Enhanced the Expression of Intestinal Uric Acid Excretion Transporter in Mice.06CC2 增强了小鼠肠道尿酸排泄转运体的表达。
Nutrients. 2024 Sep 9;16(17):3042. doi: 10.3390/nu16173042.
8
Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.铁皮石斛六君汤可改善脂乳诱导高尿酸血症大鼠尿酸排泄不足和保护肾功能障碍。
Biomed Pharmacother. 2020 Dec;132:110765. doi: 10.1016/j.biopha.2020.110765. Epub 2020 Oct 28.
9
Gender differences in mRNA expression of ATP-binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5/6 nephrectomized rats.5/6肾切除大鼠肾脏、肝脏和肠道中ATP结合盒转运体和胆汁酸转运体mRNA表达的性别差异
Drug Metab Dispos. 2008 Jan;36(1):16-23. doi: 10.1124/dmd.107.014845. Epub 2007 Sep 12.
10
ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.ABCG2功能障碍通过降低肠道尿酸排泄增加血清尿酸水平。
Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):275-81. doi: 10.1080/15257770.2013.854902.

引用本文的文献

1
Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors.用于终末期肾病患者的PBPK群体模型的开发,以了解OATP1B、BCRP、P-糖蛋白和CYP3A4介导的药物处置及个体影响因素。
Pharmaceutics. 2025 Aug 20;17(8):1078. doi: 10.3390/pharmaceutics17081078.
2
Transporter-Mediated Interactions Between Uremic Toxins and Drugs: A Hidden Driver of Toxicity in Chronic Kidney Disease.尿毒症毒素与药物之间的转运体介导相互作用:慢性肾脏病中毒性的一个隐藏驱动因素
Int J Mol Sci. 2025 Jun 30;26(13):6328. doi: 10.3390/ijms26136328.
3

本文引用的文献

1
Decreased extra-renal urate excretion is a common cause of hyperuricemia.肾脏以外尿酸排泄减少是高尿酸血症的常见原因。
Nat Commun. 2012 Apr 3;3:764. doi: 10.1038/ncomms1756.
2
Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.氯沙坦治疗中降低尿酸对肾脏结局的影响:非胰岛素依赖型糖尿病终点降低的血管紧张素Ⅱ拮抗剂氯沙坦试验的事后分析。
Hypertension. 2011 Jul;58(1):2-7. doi: 10.1161/HYPERTENSIONAHA.111.171488. Epub 2011 May 31.
3
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.
The Effects of Astaxanthin on Metabolic Syndrome: A Comprehensive Review.
虾青素对代谢综合征的影响:一项综合综述。
Mar Drugs. 2024 Dec 27;23(1):9. doi: 10.3390/md23010009.
4
Microdose Cocktail Study Reveals the Activity and Key Influencing Factors of OATP1B, P-Gp, BCRP, and CYP3A in End-Stage Renal Disease Patients.微剂量鸡尾酒研究揭示了终末期肾病患者中OATP1B、P-Gp、BCRP和CYP3A的活性及关键影响因素。
Clin Pharmacol Ther. 2025 May;117(5):1303-1312. doi: 10.1002/cpt.3546. Epub 2025 Jan 10.
5
Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease.慢性肾脏病患者尿酸代谢与肾脏结局的相关性存在性别差异。
Clin Exp Nephrol. 2023 Aug;27(8):687-700. doi: 10.1007/s10157-023-02355-9. Epub 2023 Apr 28.
6
The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD.达格列净对晚期 CKD 患者尿酸排泄和血清尿酸水平的影响。
Sci Rep. 2023 Mar 24;13(1):4849. doi: 10.1038/s41598-023-32072-y.
7
Effects of a Macroporous Resin Extract of Leaves in Rats with Hyperuricemia Induced by Anthropomorphic Unhealthy Lifestyle.拟人化不健康生活方式诱导的高尿酸血症大鼠中树叶大孔树脂提取物的作用
Evid Based Complement Alternat Med. 2023 Jan 4;2023:9990843. doi: 10.1155/2023/9990843. eCollection 2023.
8
Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.评估血液透析患者 ABCG2 介导的肾脏外尿酸排泄。
Sci Rep. 2023 Jan 13;13(1):93. doi: 10.1038/s41598-022-26519-x.
9
Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study.全基因组关联研究显示,多基因风险评分趋势和 1 号染色体上的新变异与男性痛风有关。
Arthritis Res Ther. 2022 Oct 11;24(1):229. doi: 10.1186/s13075-022-02917-4.
10
Gut-Kidney Axis Investigations in Animal Models of Chronic Kidney Disease.肠道-肾脏轴在慢性肾脏病动物模型中的研究。
Toxins (Basel). 2022 Sep 7;14(9):626. doi: 10.3390/toxins14090626.
ABCG2 是一种高容量尿酸转运蛋白,其常见缺陷可导致痛风:基于功能的日本人群遗传分析。
Sci Transl Med. 2009 Nov 4;1(5):5ra11. doi: 10.1126/scitranslmed.3000237.
4
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.高尿酸血症血清增加 1 型糖尿病患者早期肾功能进展丢失的风险:一项 6 年随访研究结果。
Diabetes Care. 2010 Jun;33(6):1337-43. doi: 10.2337/dc10-0227. Epub 2010 Mar 23.
5
Genome-wide association study of hematological and biochemical traits in a Japanese population.全基因组关联研究在一个日本人群中的血液学和生物化学特征。
Nat Genet. 2010 Mar;42(3):210-5. doi: 10.1038/ng.531. Epub 2010 Feb 7.
6
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.鉴定出一种尿酸转运蛋白ABCG2,其具有导致痛风的常见功能多态性。
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10338-42. doi: 10.1073/pnas.0901249106. Epub 2009 Jun 8.
7
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.对28141名个体进行的荟萃分析确定了五个新基因座中的常见变异,这些变异会影响尿酸浓度。
PLoS Genet. 2009 Jun;5(6):e1000504. doi: 10.1371/journal.pgen.1000504. Epub 2009 Jun 5.
8
The role of hyperuricemia in vascular disorders.高尿酸血症在血管疾病中的作用。
Curr Opin Rheumatol. 2009 Mar;21(2):132-7. doi: 10.1097/BOR.0b013e3283257b96.
9
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.葡萄糖转运蛋白9基因SLC2A9的突变会导致肾性低尿酸血症。
Am J Hum Genet. 2008 Dec;83(6):744-51. doi: 10.1016/j.ajhg.2008.11.001. Epub 2008 Nov 20.
10
Uric acid and cardiovascular risk.尿酸与心血管风险。
N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885.